Johnson & Johnson expects no new Covid vaccine revenue, after shots drive earnings beat - CNBC
- Johnson & Johnson expects no new Covid vaccine revenue, after shots drive earnings beat CNBC
- Johnson & Johnson stock declines despite Q1 earnings beat Yahoo Finance
- J&J issues cautious 2023 forecast, shares fall Yahoo Finance
- Johnson & Johnson beats on earnings and revenue, raises full-year guidance CNBC
- View Full Coverage on Google News